PANews August 25 news, according to a report by PR Newswire, the US-listed biopharmaceutical company Galmed Pharmaceuticals Ltd. announced the implementation of a digital asset management strategy, planning to allocate $10 million (approximately 50% of its current cash reserves) for digital asset investments. The company has established a cryptocurrency committee responsible for evaluating and overseeing cryptocurrency-related investment activities. This strategy will include digital asset portfolio rebalancing, participation in liquidity provision, staking yields, and risk hedging strategies, among others. To execute this plan, Galmed has signed a letter of intent with cryptocurrency asset management service provider Tectona, which will provide consulting and operational services.